2019
DOI: 10.1016/j.yexcr.2018.12.002
|View full text |Cite
|
Sign up to set email alerts
|

Zinc and p53 disrupt mitochondrial binding of HK2 by phosphorylating VDAC1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 43 publications
1
18
0
Order By: Relevance
“…Voltage-dependent anion channel 1 (VDAC1) is an important regulator of mPTP opening. HK2 interacts with VDAC1 to change the conformation of VDAC1, which leads to an inhibition of mPTP opening [48][49][50]. This correlates with our discovery that silencing HK2, the target of miR-22, aggravates TGEV-induced mPTP opening.…”
Section: Discussionsupporting
confidence: 83%
“…Voltage-dependent anion channel 1 (VDAC1) is an important regulator of mPTP opening. HK2 interacts with VDAC1 to change the conformation of VDAC1, which leads to an inhibition of mPTP opening [48][49][50]. This correlates with our discovery that silencing HK2, the target of miR-22, aggravates TGEV-induced mPTP opening.…”
Section: Discussionsupporting
confidence: 83%
“…Mitochondria-localized HK2 has been shown to be required for escaping from mitochondrial cell death in several types of human cancer [28][29][30][31]. Here, we found that xanthohumol suppressed HK2 expression and induced the activation of mitochondrial apoptosis signaling.…”
Section: Discussionmentioning
confidence: 63%
“…In previous sections, we dealt with the anito‐apoptotic role of hexokinase 2. Therefore, it is possible that phachymic acid may be able to induce apoptosis through mechanisms such as separating HK2 from the mitochondrial membrane (Miao et al, 2019; Xue et al, 2019). In addition, phachymic acid can increase the expression of PTEN and attenuate AKT/PI3K signaling pathway in cancer cells (Wen et al, 2018).…”
Section: Metabolism As Target For Cancer Treatmentmentioning
confidence: 99%